---
authors: 
institution: 
project: 
tags: [MED]
status: 
aliases: Clotting
type: Process
date created: 08/27/2023, 07:55
date modified: 09/20/2023, 08:12
---

(Back to [[ref/Heme_Lymph Atlas|Heme_Lymph Atlas]])

# Hemostasis

Rapid formation of a **thrombus**
## Process
All of this happens basically simultaneously.
- Release of [[PDGF]] and [[TGF-beta]] growth factors
- Vasoconstriction
- Release of [[von Willebrand factor]]
- [[primary hemostasis]] - platelet-mediated ("clotting"; "platelet plug")
- [[secondary hemostasis]] - factor-mediated ("coagulation"; "fibrin mesh")
- [[anticoagulation]] - inhibition of clotting
- [[fibrinolysis]] - degradation of clot
## Pathologies
- Primary hemostasis disorders
	- Platelet destruction ([[thrombocytopenia]])
		- [[immune thrombocytopenic purpura]] - antibodies against platelets
	- Platelet function defects
		- [[ref/Bernard-Soulier syndrome|Bernard-Soulier syndrome]] - adhesion defect (Gp1b)
		- [[ref/Glanzmann's thrombasthenia|Glanzmann's thrombasthenia]] - aggregation defect (GpIIbIIIa)
- Secondary hemostasis disorders (factor function)
	- [[ref/von Willebrand disease|von Willebrand disease]] - low, missing, defective vWF
	- [[hemophilia A]] - missing FVIII
	- [[hemophilia B]] - missing FIX
	- [[hemophilia C]] - missing FXI
	- [[FVII deficiency]]
	- [[Factor V Leiden]] - FVa resistant to APC degradation
	- [[prothrombin G20210A]] - increased prothrombin expression
	- [[vitamin K deficiency]] - defective FII, FVII, FIX, FX, protein C, protein S
	- [[liver coagulopathy]]
- Anticoagulation disorders
	- [[Protein C deficiency]]
	- [[Protein S deficiency]]
	- [[antithrombin deficiency]]
	- [[hyperhomocysteinemia]]
	- [[elevated FVIII]]
	- [[antiphospholipid antibody syndrome]]
- Fibrinolytic disorders
	- 
- Iatrogenic
	- Aspirin-induced
		- Bleeding
	- Warfarin-induced
		- [[warfarin skin necrosis]] - transient decrease in Protein C/S causes hypercoagulability
	- Heparin-induced
		- [[heparin-induced thrombocytopenia]] - immune destruction of heparin-bound platelets (PF4)
- Excessive clotting
	- [[disseminated intravascular coagulation]]
	- [[thrombosis]]

## Therapies
- Platelet-stimulating agents
	- Thrombopoeitin (TPO) agonists
		- [[eltrombopag]]
		- [[romiplostim]]
- Platelet function inhibitors
	- [[aspirin]] - not reversible
- Factor replacement
	- [[FFP]] - fresh-frozen plasma
	- [[PCC]] - activated prothrombin complex concentrate
	- [[FEIBA]] - factor eight bypassing agent
	- [[DDAVP]] - vasopressin analog
- Anticoagulation
	- Direct oral anticoagulants (DOACs)
		- Thrombin inhibitors
			- [[dabigatran]]
		- Xa inhibitors
			- [[rivaroxaban]]
	- Vitamin K inhibitors
		- [[warfarin]]
	- Antithrombin cofactors
		- [[heparin]]
		- [[fondaparinux]] - if bleeding risk
 - Antifibrinolytics
	 - [[aminocaproic acid]]
	 - [[tranexamic acid]]
	 - [[tissue plasminogen activator]] - reserved for emergencies
- Reversal agents
	- [[vitamin K]] - for Warfarin
	- [[protamine]] - for heparin